Cipla Medpro

Cape Town, South Africa Founded: 1998 • Age: 28 yrs Acquired By Cipla
Generic pharmaceuticals are manufactured and marketed for South African customers.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products 4 Services tracked
Competitors - Brand Intelligence

About Cipla Medpro

Cipla Medpro is a company based in Cape Town (South Africa) founded in 1998 was acquired by Cipla in February 2013. Cipla Medpro has completed 2 acquisitions, including Actor Pharma and Anmarate. Cipla Medpro offers products and services including Asthma Inhalers, HIV Treatments, Antibiotics, and Diabetes Medications.

  • Headquarter Cape Town, South Africa
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
  • Investments & Acquisitions
  • Acquired by
    Cipla

    (Feb 28, 2013)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Cipla Medpro

Cipla Medpro offers a comprehensive portfolio of products and services, including Asthma Inhalers, HIV Treatments, Antibiotics, and Diabetes Medications.

Product name locked
Category locked
Primary

Medications for managing asthma symptoms effectively.

Product name locked
Category locked
Locked

Drugs for suppressing HIV and supporting patient care.

Product name locked
Category locked
Locked

Medicines to treat bacterial infections and promote recovery.

Product name locked
Category locked
Locked

Products for controlling blood sugar levels in diabetes.

People of Cipla Medpro

Headcount 200-500
Employee Profiles 27
Employee Profiles
People
Dr. Cyprian Cele (PhD)
Director: Human Resources
People
Rene Pearce
Senior Product Manager: RX
People
Natashia Enslin
Deputy Manager - Events
People
Bernice Leonard
Head, Internal Agency

Unlock access to complete

Funding Insights of Cipla Medpro

Premium access

Detailed funding history for Cipla Medpro

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in Cipla Medpro

Cipla Medpro has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Cipla.

All
Institutional
Investor Description Founded Year Domain Location
APIs, generic drugs, and formulation services are manufactured.
Locked Locked Locked
Premium access

Investor details for Cipla Medpro

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Cipla Medpro

Cipla Medpro has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Actor Pharma and Anmarate.

Investments
Premium access

Investment portfolio details for Cipla Medpro

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
Over-the-counter drugs are manufactured in South Africa.
Locked Locked 2009 Locked
R&D company focused on manufacturing of drugs for multiple therapeutic areas
Locked Locked 1996 Locked
Premium access

Complete acquisition details for Cipla Medpro

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - Cipla Medpro

Premium access

Detailed financials for Cipla Medpro

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Cipla Medpro Comparisons

Cipla Medpro Primary company
Description
Generic pharmaceuticals are manufactured and marketed for So...
Location
Cape Town, South Africa
Founded Year
1998
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Cipla Medpro

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Cipla Medpro

Premium access

Detailed competitors of Cipla Medpro

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Cipla Medpro

Premium access

Complete news archive for Cipla Medpro

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Cipla Medpro

Cipla Medpro was founded in 1998.

Cipla Medpro is headquartered in Cape Town, South Africa. It is registered at Cape Town, Western Cape, South Africa.

Cipla Medpro was established in 1998 in Cape Town, South Africa, as a subsidiary fully owned by Cipla India. Generic medicines are produced and distributed primarily within the South African market, where the company operates in the pharmaceutical sector. Additional divisions include Cipla Vet for small animal and equine products, Cipla Agrimed for production animals, and Cipla Nutrition for sports supplements. Operations focus on volume-based manufacturing across these areas.

Cipla Medpro offers Asthma Inhalers, HIV Treatments, Antibiotics, and Diabetes Medications.

Cipla Medpro has made 2 acquisitions, including Actor Pharma, and Anmarate.

Cipla Medpro has 1 investor. Key investors include Cipla.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available